EUVIMEDEUVIMED entdecken
Crossref

VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis

Shinichiro Nishimi iD, Sayaka Fukuse, Yusuke Miwa, Kuninobu Wakabayashi, Takeo Isozaki

Modern Rheumatology · 2025

DOI: 10.1093/mr/roae107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Shinichiro Nishimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Cadherins, Antigens, CD, Inflammation. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

A disintegrin and metalloproteinase (ADAM)-15 and vascular endothelial (VE)-cadherin are involved in angiogenesis. We investigated the relationship between ADAM-15 and VE-cadherin expressions in rheumatoid arthritis (RA).

Methods

VE-cadherin concentrations in the serum of patients with RA were measured using the enzyme linked immunosorbent assay. We stimulated fibroblast-like synoviocytes (RA-FLS) with VE-cadherin and measured the vascular endothelial growth factor (VEGF) and inflammatory cytokine levels using ELISA. We also examined the correlation between serum VE-cadherin levels and DAS-28ESR, and used the Matrigel assay to examine VE-cadherin involvement in angiogenesis.

Results

Serum VE-cadherin levels were significantly higher in patients with RA than in healthy controls. A negative correlation was observed between VE-cadherin and DAS-28ESR. VEGF, chemokine ligand 16, intercellular adhesion molecule-1, and interleukin-8 levels in the supernatant of RA-FLS or human umbilical vein endothelial cells stimulated with VE-cadherin were significantly lower than those in the controls. The number of intercellular bridges formed by endothelial cells using Matrigel significantly decreased in RA synovial fluids from which VE-cadherin had been removed compared to synovial fluids treated with control immunoglobulin G.

Conclusion

VE-cadherin may have an inhibitory effect on inflammation depending on the phase of RA inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidCadherinsAntigens, CDInflammationHumansFemaleMaleMiddle AgedSynoviocytesAdultVascular Endothelial Growth Factor AAgedHuman Umbilical Vein Endothelial CellsSynovial FluidCadherin 5

Stichwörter der Autor:innen

ADAM-15VE-cadherinangiogenesisrheumatoid arthritis

Substanzen

CadherinsAntigens, CDVascular Endothelial Growth Factor ACadherin 5

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Department of Pathogenesis and Translational Medicine, Showa University Graduate School of Pharmacy, Tokyo, Japan.

ORCID-Profile: Shinichiro Nishimi

Zitieren

APA

Nishimi, S., Fukuse, S., Miwa, Y., Wakabayashi, K., & Isozaki, T. (2025). VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis. Modern Rheumatology. https://doi.org/10.1093/mr/roae107

Vancouver

Nishimi S, Fukuse S, Miwa Y, Wakabayashi K, Isozaki T. VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis. Modern Rheumatology. 2025. doi:10.1093/mr/roae107

BibTeX
@article{Nishimi2025,
  author = {Nishimi, Shinichiro and Fukuse, Sayaka and Miwa, Yusuke and Wakabayashi, Kuninobu and Isozaki, Takeo},
  title = {VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roae107}
}
Kostenlos starten →